{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:40:07Z","timestamp":1750005607902,"version":"3.41.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>Complement deficient patients are susceptible to rare meningococcal serogroups. A 6-year-old girl presented with serogroup Z meningitis. This led to identification of a C8 deficiency. The MenB-4C vaccine induced cross-reactive antibodies to serogroup Z and increased in vitro opsonophagocytic killing and may thus protect complement deficient patients.<\/jats:p>","DOI":"10.1097\/inf.0000000000003259","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T03:01:59Z","timestamp":1626836519000},"page":"1019-1022","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Neisseria meningitidis Serogroup Z Meningitis in a Child With Complement C8 Deficiency and Potential Cross Protection of the MenB-4C Vaccine"],"prefix":"10.1097","volume":"40","author":[{"given":"Bryan","family":"van den Broek","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases and Immunology, Amalia Children\u2019s Hospital, Nijmegen, the Netherlands"},{"name":"Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordy P. M.","family":"Coolen","sequence":"additional","affiliation":[{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"},{"name":"Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[{"name":"Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"de Groot","sequence":"additional","affiliation":[{"name":"Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie S. V.","family":"Henriet","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunology, Amalia Children\u2019s Hospital, Nijmegen, the Netherlands"},{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"},{"name":"Expertise Center for Immunodeficiency and Autoinflammation (REIA), Radboudumc, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen D.","family":"Langereis","sequence":"additional","affiliation":[{"name":"Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"van der Flier","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunology, Amalia Children\u2019s Hospital, Nijmegen, the Netherlands"},{"name":"Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands"},{"name":"Expertise Center for Immunodeficiency and Autoinflammation (REIA), Radboudumc, Nijmegen, the Netherlands"},{"name":"Pediatric Infectious Diseases and Immunology, Wilhelmina Children\u2019s Hospital, University Medical Center, Utrecht, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"issue":"suppl 2","key":"R1-20250615","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease.","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molimm.2011.05.001","article-title":"Complement deficiency states and associated infections.","volume":"48","author":"Skattum","year":"2011","journal-title":"Mol Immunol"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3476(89)80793-0","article-title":"Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis.","volume":"114","author":"Nagata","year":"1989","journal-title":"J Pediatr"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/515075","article-title":"Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.","volume":"28","author":"Fijen","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2019.00683","article-title":"Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines.","volume":"10","author":"Petousis-Harris","year":"2019","journal-title":"Front Immunol"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14760584.2017.1308828","article-title":"Emerging experience with meningococcal serogroup B protein vaccines.","volume":"16","author":"Toneatto","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1080\/21645515.2020.1855951","article-title":"Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.","volume":"17","author":"Fazio","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cei.13368","article-title":"Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency.","volume":"198","author":"van den Broek","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/bloodadvances.2020002497","article-title":"Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients.","volume":"4","author":"Langereis","year":"2020","journal-title":"Blood Adv"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"42137","DOI":"10.1038\/srep42137","article-title":"A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood.","volume":"7","author":"van der Maten","year":"2017","journal-title":"Sci Rep"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.4049\/jimmunol.155.10.5022","article-title":"Delineation of additional genetic bases for C8 beta deficiency. Prevalence of null alleles and predominance of C\u2013>T transition in their genesis.","volume":"155","author":"Saucedo","year":"1995","journal-title":"J Immunol"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.vaccine.2014.01.011","article-title":"Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero\u00ae vaccine.","volume":"32","author":"Tani","year":"2014","journal-title":"Vaccine"},{"journal-title":"Clin Infect Dis","article-title":"First real world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease; prospective enhanced national surveillance, England [published online ahead of print August 26, 2020].","author":"Ladhani","key":"R13-20250615"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","article-title":"Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).","volume":"19","author":"Ladhani","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"e20162452","DOI":"10.1542\/peds.2016-2452","article-title":"Meningococcal B vaccine failure with a Penicillin-Resistant strain in a young adult on long-term eculizumab.","volume":"140","author":"Parikh","year":"2017","journal-title":"Pediatrics"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3201\/eid2408.180228","article-title":"Fatal nongroupable neisseria meningitidis disease in vaccinated patient receiving eculizumab.","volume":"24","author":"Nolfi-Donegan","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/S0264-410X(03)00440-7","article-title":"Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine.","volume":"21","author":"Platonov","year":"2003","journal-title":"Vaccine"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020.","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:27Z","timestamp":1750003407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003259","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}